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Abstract Cardiac resynchronization therapy (CRT) in multiple and large trials has been 
demonstrated to improve symptoms and decrease hospitalization and mortality of patients 
when used in addition to optimal medical therapy. The global mechanical performance of 
the heart is affected in subjects with heart failure by atrio-ventricular, interventricular, or 
intraventricular conduction disorders, which lead to the desynchronization of electrical 
activity. Cardiac resynchronization therapy can effectively improve the clinical and 
haemodynamic status of these patients.    
According to literature data, CRT is performed only on well-selected patients (who 
qualify for CRT based on current indications), and approximately 70% of those patients 
respond favorably. We present the case of a patient responsive to cardiac 
resynchronization therapy which led to lowering of his NYHA classification and to 
improvement of left ventricle hemodynamics. The benefits of cardiac resynchronization 
therapy were multiple in this case, including improved tolerance to physical exercise and 
a decreased rate of hospitalization, which overall led to improved quality of life. 
  
 
Keywords  heart failure, ischemic cardiomyopathy, cardiac resynchronization therapy 
Highlights ✓ CRT is best performed only on well-selected patients who qualify based on current 
indications, and approximately 70% of patients respond favorably.  
✓ CRT improves symptoms and decreases hospitalizations and mortality when used in 
addition to optimal medical therapy.          
  
 
Acne conglobata is a rare, severe form of acne vulgaris characterized by the presence of comedones, 
papules, pustules, nodules and ometimes hematic or meliceric crusts, located on the face, trunk, neck, arms 
and buttocks.  
 
Case Report 
We report the case of a 16 year old Caucasian female patient from the urban area who addressed our 
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Introduction 
The management of chronic heart failure has the 
following primary objectives: symptom relief, preventing 
major morbidity, decreasing mortality, and preventing 
disease progression by preventing the evolution of the left 
ventricular dysfunction in heart failure clinically objectified 
(1, 2).    
The most common causes leading to heart failure are 
represented by coronary artery disease (including but not 
limited to previous myocardial infarction), atrial fibrillation, 
high blood pressure, valvular heart disease, infections, 
excess alcohol use, and cardiomyopathy related to unknown 
causes. All such causes lead to heart failure by changing the 
structure and/or functioning of the heart. Chronic heart 
failure is generally a common, expensive, and potentially 
fatal condition for some individuals (3). 
The global mechanical performance of the heart is 
affected by heart muscle impairment and conduction 
disorders (atrio-ventricular, interventricular or 
intraventricular), which lead to desynchronization of the 
electrical activity and thus to heart failure. An effective 
cardiac resynchronization therapy is generally able to 
improve not only haemodynamic status but also the clinical 
condition of the patient. Benefits of cardiac 
resynchronization therapy include an improved tolerance to 
physical exercise, reduced heart remodeling, decreased 
mortality rate, and a decreased rate of hospitalization in 
patients with sinus rhythm (4, 5).        
This paper presents the case of a responder patient to 
cardiac resynchronization therapy, characterized by a 
significant decrease of symptomatology and substantial 
increased capacity for physical effort, thereby improving the 
patient’s quality of life. 
 
Case Report 
Our presentation involves a 66-year-old patient, former 
smoker, hypertensive with maximum pressure values of 250 
mmHg since 1999, with diabetes since 2004 in treatment 
with oral antidiabetic drugs, also known with inferior 
myocardial infarction in 1996, anterior myocardial 
infarction in 2013, with ambulatory treatment correctly 
taken, who came to the cardiology service for dyspnea of 
rest with orthopnea, accompanied by fatigue, headache, and 
dizziness. 
Regarding his physical examination, the patient was a 
fatigued, well nourished, awake and orientated, 
normocephalic, atraumatic individual with both pupils 
equally round and reactive to light and accommodation. His 
oculomotricity was normal, he presented intact tympanic 
membrane bilaterally, mucous membranes moist and 
anicteric sclera. His neck did not present any 
lymphadenopathy, carotid bruit, or jugular vein distension. 
Regarding the cardiovascular examination, he presented 
precordial area with a normal aspect, apical impulse in the 
VIth left intercostal space outside the left medioclavicular 
line, he had a regular heart rhythm (about 83 beats per 
minute) and a 3/6 systolic murmur in the Vth left intercostal 
space on the left medioclavicular line, with radiation in the 
axilla and no hepatojugular reflux; peripheral pulse was 
present. His blood pressure was 130/80mmHg. Lung 
examination revealed: murmur slightly diminished bilateral 
basal, rare rales on both pulmonary areas, no alteration in 
the tactile fremitus and normal percution. The abdomen had 
no pulsatile masses, being non-distended and resonant to 
percussion; liver and spleen had normal dimensions. I-ntact, 
normal colored and with normal temperature teguments, 
cyanosis was not present at the extremities. Neurological 
and psychiatric examinations were normal. 
Regarding laboratory tests, the patient presented the 
following: at complete blood count a value of 13.7g/dl for 
hemoglobin, 42.4% for hematocrit, 6540/mm3 for 
leukocytes and 163000/mm3 for platelets; a level of blood 
glucose of 168mg/dl; slightly influenced renal function 
(creatinine of 1.24 mg/dl); and the constants for the hepatic 
function (GOT, GPT, γ-GT, ALP, total, direct and indirect 
bilirubin), the constants for the lipid profile (total 
cholesterol, triglycerides, LDL and LDH), and the values of 
the electrolytes (Na+, K+, Ca++, MG ++, Cl-) were normal.  
His 12-lead electrocardiogram (ECG) before cardiac 
resynchronization therapy (CRT) showed a QRS width of 
175 ms (Figure 1), while after CRT QRS width was 120 ms 
(Figure 2).   
 
Figure 1. 12-lead electrocardiogram (ECG) showed 
complete left bundle branch block (LBBB) with a QRS 
width of 175 ms, before therapy with a cardiac 
resynchronization device. 
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Figure 2. 12-lead electrocardiogram (ECG) after 
cardiac resynchronization therapy (CRT), showed a 
QRS width of 120 ms. 
 Some echocardiographic aspects revealed in the 
transthoracic echocardiographic examination before and 
after CRT are presented in Figures 3-9.  
 
Figure 3. Assessment of myocardial strain from the 
apical four-chamber view, before therapy with a cardiac 
resynchronization device.  
 
Figure 4. Two-dimensional echocardiography revealed 
a severely impaired left ventricular (LV) function with a 
low LV ejection fraction (LVEF) of 10 % assessed 
according to the modified Simpson method, before 
therapy with a cardiac resynchronization device.  
 
Figure 5. Two-dimensional echocardiography 
revealed an improvement in left ventricular (LV) 
function with a low LV ejection fraction (LVEF) 
of 25 % assessed according to the modified 
Simpson method, after therapy with a cardiac 
resynchronization device.   
 
 
Figure 6.  Mitral regurgitation (highlighted as 
multicolored mosaic pattern, green and yellow), 
before therapy with a cardiac resynchronization 
device.  
 
 
Figure 7. Mitral regurgitation (highlighted as 
multicolored mosaic pattern, green and yellow), 
after therapy with a cardiac resynchronization 
device. 
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Figure 8. Aspect of waveforms of tissue Doppler 
interrogation at the interventricular septum before 
therapy with a cardiac resynchronization device (yellow 
color).   
 
Figure 9.  Aspect of waveforms of tissue Doppler 
interrogation at the interventricular septum after therapy 
with a cardiac resynchronization device (yellow color).  
Coronary arteriography (right radial approach) showed 
a right dominant coronary system. Left main coronary artery 
diffusely infiltrated, distal stenosis 50%. Left anterior 
descending artery with 70% ostial stenosis; 80% proximal 
stenosis of the left anterior descending artery appeared on an 
ulcerated plaque. 90% marginal I stenosis, important vessel. 
Left circumflex artery with 70% stenosis right after the 
ostium. Occlusion of the right coronary artery at the origin. 
Right coronary artery’s periphery is filled by the 
contralateral collateral circulation.  
The coronary arteriography showed important 
trivascular lesions, graftable vessels. Thus, “off pump” 
surgical myocardial revascularization (with high risk) and 
subsequently implanting a defibrillator cardioverter with 
cardiac resynchronization therapy (CRT-D) were 
considered. 
 
Discussion 
Hemodynamic effects caused by short left or right 
ventricle stimulation were described for the first time about 
50 years ago. However, cardiac resynchronization therapy 
was firstly applied in 1994, when Cazeau et al. in France 
and Bakker in the Netherlands described the first cases of 
atrium-biventricular stimulation in patients suffering from 
heart failure refractory to drug therapy, having no 
indications for cardiac stimulation (4–6). 
Desynchronization of the electrical and mechanical 
activity of the heart cavities is a pathophysiological process 
which directly affects the hemodynamic parameters of the 
heart by decreasing the ventricular function, by left 
ventricular remodeling, and by worsening heart failure. As a 
consequence, the risk of morbidity and mortality rises. For 
patients with preexisting cardiomyopathy, the left ventricle 
dysfunction is further worsened by atrioventricular and 
intraventricular conduction disorders (1). Also, left ventricle 
contraction is altered by the existence of the left branch 
block, which causes either the delay or the premature 
contraction of the parietal segments, thus affecting 
myocardial flow distribution and the regional metabolism by 
not uniformizing it, and also molecular changes caused by 
certain enzymatic systems or by calcium ions (7–9). As with 
the patient described in this paper, intraventricular 
desynchronization caused by the existence of the left branch 
block favors mitral failure and shortens the filling time of 
the left ventricle (10, 11). 
Many studies have confirmed a significant 
improvement in symptomatology and increased exercise 
capacity after applying cardiac resynchronization therapy in 
patients diagnosed with chronic cardiac failure, also 
presenting atrioventricular and intraventricular conduction 
disorders, with optimal medical therapy (12-14). 
As in our case, the European Society of Cardiology 
(ESC) Guidelines for the diagnosis and treatment of acute 
and chronic heart failure from 2016 mention that cardiac 
resynchronization therapy (CRT) has a  1st  Class, A level, 
indication in symptomatic patients with heart failure (HF) in 
sinus rhythm with QRS duration ≥ 150 ms and LBBB QRS 
morphology, and with left ventricular ejection fraction ≤ 
35%, despite optimal medical therapy, in order to improve 
symptoms and reduce morbidity and mortality (15-18).  
 
Conclusions 
Cardiac resynchronization therapy (CRT) has been 
shown in multiple and large trials that it improves symptoms 
and decreases hospitalizations and mortality when used in 
addition to optimal medical therapy. CRT is best performed 
only on well-selected patients who qualify based on current 
indications, and approximately 70% of patients respond 
favorably.  
The effectiveness of cardiac resynchronization therapy 
for the presented case report was confirmed by lowering 
NYHA class and by improving the left ventricle’s 
hemodynamics. Generally, the benefits of cardiac 
resynchronization therapy are multiple, including an 
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improved tolerance to physical exercise, reduced heart 
remodeling, decreased mortality, and finally a decreased rate 
of hospitalization in patients with sinus rhythm. 
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